高级检索
当前位置: 首页 > 详情页

Quercetin alleviates rheumatoid arthritis by inhibiting neutrophil inflammatory activities

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China [2]Division of Interdisciplinary Medicine and Biotechnology, Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA [3]The Seventh Affiliated Hospital,Sun Yat-sen University, Guangzhou, China [4]State Key Laboratory of Biocontrol, Department of Biochemistry, School of Life Sciences,Sun Yat-Sen (Zhongshan) University, Guangzhou, Guangdong, China
出处:
ISSN:

关键词: Rheumatoid arthritis Quercetin Neutrophils Inflammation Autophagy NETosis Apoptosis

摘要:
Rheumatoid arthritis (RA) is a prototypical autoimmune disorder mainly characterized by joint inflammation and cartilage destruction. Neutrophils actively take part in the initiation and progression of RA. Neutrophils express inflammatory mediators, including cytokines and chemokines. Aberrant formation of neutrophil extracellular traps (NETs) has been demonstrated in the pathogenesis of RA. Thus, neutrophils are regarded as important therapeutic targets in RA treatment. Quercetin is one of the major flavonoids found in fruits and vegetables. Previous studies have demonstrated that quercetin is a potential agent for the treatment of RA. However, the underlying antiarthritic mechanism of quercetin has not been investigated clearly. In this study, we analyzed the therapeutic mechanism of quercetin for RA. Our results showed that quercetin ameliorates inflammation in RA mice by inhibiting neutrophil activities. Quercetin inhibited neutrophil infiltration and reduced the plasma levels of inflammatory cytokines. Quercetin promoted the apoptosis of activated neutrophils. In addition, quercetin inhibited NET formation by suppressing autophagy. These findings suggest that quercetin may be an alternative agent for the treatment of RA by inhibiting neutrophil activities. (C) 2020 Elsevier Inc. All rights reserved.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 营养学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 营养学
JCR分区:
出版当年[2018]版:
Q1 NUTRITION & DIETETICS Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China [2]Division of Interdisciplinary Medicine and Biotechnology, Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA
共同第一作者:
通讯作者:
通讯机构: [1]School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China [4]State Key Laboratory of Biocontrol, Department of Biochemistry, School of Life Sciences,Sun Yat-Sen (Zhongshan) University, Guangzhou, Guangdong, China [*1]School of Life Sciences, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People’s Republic of China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号